Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
 3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Revenue:        
Products, services, other $ 372,545 $ 327,958 $ 1,084,156 $ 746,050
Grant revenue    92,804    403,186
Total revenue 372,545 420,762 1,084,156 1,149,236
Costs and expenses:        
Cost of products and services 149,065 175,995 461,124 364,368
Research and development 232,032 280,276 716,358 787,142
Selling and marketing 188,129 190,882 555,543 573,174
General and administrative 600,952 617,642 1,777,887 1,851,634
Total operating costs and expenses 1,170,178 1,264,795 3,510,912 3,576,318
Operating loss (797,633) (844,033) (2,426,756) (2,427,082)
Other (expense) income:        
Interest expense (179,942) (158,162) (658,255) (230,176)
Other expense (80,102) (2,132) (80,102) (210,838)
Change in fair value of derivative liabilities 98,627 331,113 (156,779) 349,472
Total other (expense) income (161,417) 170,819 (895,136) (91,542)
Net loss (959,050) (673,214) (3,321,892) (2,518,624)
Accrued dividends on convertible preferred stock (43,362) (42,938) (97,955) (114,348)
Deemed dividends on convertible preferred stock       (1,388,062) (651,182)
Net loss applicable to common shareholders $ (1,002,412) $ (716,152) $ (4,807,909) $ (3,284,154)
Net loss per share attributable to common stockholders - basic and diluted $ (0.07) $ (0.06) $ (0.35) $ (0.28)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 15,238,466 11,664,484 13,648,795 11,776,740